The Company projects 2023 revenues to be greater than $2.75 billion vs consensus of $2.81B, and projects 2023 Adjusted EBITDA to be greater than $425 million.
Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...
Reports Q3 revenue $770.4M, consensus $769.76M. Eric Evans, Chief Executive Officer, stated, “Surgical case volume, particularly in higher acuity and strategically important growth areas, remained ...